News and Milestones

Dextera Surgical’s Microcutter 5/80™ And Cardiac Anastomotic Devices To Be Featured At The 31st Annual European Association For Cardio-Thoracic Surgery

REDWOOD CITY, Calif. – October 9, 2017 – Dextera Surgical today announced that several leading surgeons will feature the use of Dextera Surgical’s MicroCutter 5/80™ Stapler and its C-Port® Distal Anastomosis Systems in three oral presentations at the 31st Annual European Association for Cardio-Thoracic Surgery. The meeting is taking......Read More

Dextera Surgical Hosts Hands-On Training Course For Video-Assisted Thoracic Surgery Techniques Using Microcutter 5/80™ For Segmentectomy

REDWOOD CITY, Calif. – September 27, 2017 – Dextera Surgical today announced that it sponsored an international hands-on training course for thoracic surgeons from across Europe focused on advanced techniques for video-assisted thoracic surgery (VATS). During this day-long event in Tubingen, Germany, a faculty of world-leading thoracic surgeons taught......Read More

Dextera Surgical Receives Expanded Indication In Solid Organ Surgery For Microcutter 5/80™

REDWOOD CITY, Calif. – August 30, 2017 – Dextera Surgical Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to use its MicroCutter 5/80 Stapler and MicroCutter 30 White and Curved Tip White Reloads in conjunction with open solid organ parenchymal dissection......Read More

Dextera Surgical To Present At Southern California Investor Conference

REDWOOD CITY, Calif. – August 21, 2017 – Dextera Surgical Inc. today announced that Julian Nikolchev, president and CEO, will present a corporate update at the Southern California Investor Conference in Newport Beach, CA on Thursday, August 24, 2017, at 8:30 a.m. Pacific Time.   To access the live......Read More

Dextera Surgical’s Automated Cardiac Anastomotic Devices To Be Featured At 2017 International Coronary Congress

REDWOOD CITY, Calif. – August 17, 2017 – Dextera Surgical Inc. today announced that its C-Port® Distal and PAS-Port® Proximal Anastomosis Systems will be highlighted in multiple lectures, abstracts and presentations for their ability to enable less invasive cardiac procedures at the 2017 International Coronary Congress (ICC), a medical......Read More

Dextera Surgical To Present At 2017 Wedbush PacGrow Healthcare Conference

REDWOOD CITY, Calif. – August 14, 2017 – Dextera Surgical Inc. today announced that Julian Nikolchev, president and CEO, will present a corporate update at the 2017 Wedbush PacGrow Healthcare Conference in New York on Wednesday, August 16, 2017 at 8:35 a.m. Eastern Time. To access the live and......Read More

Dextera Surgical Reports Fiscal 2017 Fourth Quarter Financial Results

REDWOOD CITY, Calif. – August 8, 2017 – Dextera Surgical Inc today announced financial results for its fiscal fourth quarter and full year ended June 30, 2017. Management will hold a conference call at 4:30 p.m. Eastern Time to discuss financial results and provide an update on the company’s......Read More

Dextera Surgical Implements Temporary Shipping Hold On Microcutter 5/80™

REDWOOD CITY, Calif. – July 6, 2017 – Dextera Surgical Inc. today announced that it placed a temporary shipping hold on the MicroCutter 5/80 Stapler and reload cartridges in response to six reports that surgeons were unable to clamp the MicroCutter 5/80 Stapler after inserting a MicroCutter 30 Reload......Read More

Dextera Surgical’s Microcutter 5/80™ And Cardiac Anastomosis Devices Featured At International Society For Minimally Invasive Cardiothoracic Surgery Conference

REDWOOD CITY, Calif. – June 12, 2017 – Dextera Surgical Inc. today announced that several leading surgeons highlighted the use of Dextera’s C-Port® Distal and PAS-Port® Proximal Anastomosis Systems as well as the MicroCutter 5/80 Stapler in a variety of less invasive surgical procedure presentations at the 14th Annual......Read More

Dextera Surgical Files 510(k) For Expanded Indications

REDWOOD CITY, Calif. – June 1, 2017 – Dextera Surgical Inc today announced that it has filed a 510(k) with the U.S. Food and Drug Administration for expanded indications for use. The company seeks to expand the indications for the MicroCutter to include liver, pancreas, kidney and spleen surgery.......Read More